Trademark: 88976214
Word
CC CELULARITY
Status
Registered
Status Code
700
Status Date
Tuesday, January 7, 2020
Serial Number
88976214
Registration Number
5957944
Registration Date
Tuesday, January 7, 2020
Mark Type
5000
Filing Date
Wednesday, June 27, 2018
Published for Opposition
Tuesday, October 30, 2018

Trademark Owner History
CELULARITY INC. -
Celularity, Inc. - Original Registrant

Classifications
42 Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing written materials and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing
The mark consists of a purple tilted "C" next to a green backwards tilted "C" forming an infinity symbol above the word "CELULARITY" in purple.
The color(s) purple and green is/are claimed as a feature of the mark.

Trademark Events
Jan 12, 2022
Automatic Update Of Assignment Of Ownership
Oct 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 8, 2020
Teas Change Of Correspondence Received
Oct 8, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 8, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 8, 2020
Teas Change Of Owner Address Received
Jan 7, 2020
Registered-Principal Register
Dec 4, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 3, 2019
Allowed Principal Register - Sou Accepted
Nov 8, 2019
Statement Of Use Processing Complete
Oct 29, 2019
Use Amendment Filed
Nov 8, 2019
Divisional Processing Complete
Oct 29, 2019
Divisional Request Received
Nov 8, 2019
Case Assigned To Intent To Use Paralegal
Oct 29, 2019
Teas Request To Divide Received
Oct 29, 2019
Teas Statement Of Use Received
May 30, 2019
Notice Of Approval Of Extension Request E-Mailed
May 28, 2019
Sou Extension 1 Granted
May 28, 2019
Sou Extension 1 Filed
May 28, 2019
Sou Teas Extension Received
Dec 25, 2018
Noa E-Mailed - Sou Required From Applicant
Oct 30, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 30, 2018
Published For Opposition
Oct 10, 2018
Notification Of Notice Of Publication E-Mailed
Sep 23, 2018
Assigned To Lie
Sep 8, 2018
Approved For Pub - Principal Register
Sep 5, 2018
Teas/Email Correspondence Entered
Sep 4, 2018
Correspondence Received In Law Office
Sep 4, 2018
Teas Request For Reconsideration Received
Aug 30, 2018
Notification Of Final Refusal Emailed
Aug 30, 2018
Final Refusal E-Mailed
Aug 30, 2018
Final Refusal Written
Aug 9, 2018
Teas/Email Correspondence Entered
Aug 9, 2018
Correspondence Received In Law Office
Aug 9, 2018
Teas Response To Office Action Received
Jul 24, 2018
Notification Of Non-Final Action E-Mailed
Jul 24, 2018
Non-Final Action E-Mailed
Jul 24, 2018
Non-Final Action Written
Jul 23, 2018
Assigned To Examiner
Jul 1, 2018
New Application Office Supplied Data Entered
Jun 30, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24